Skip to main content

Main menu

  • Home
  • Content
    • Current
    • Ahead of print
    • Past Issues
    • JNM Supplement
    • SNMMI Annual Meeting Abstracts
    • Continuing Education
    • JNM Podcasts
  • Subscriptions
    • Subscribers
    • Institutional and Non-member
    • Rates
    • Journal Claims
    • Corporate & Special Sales
  • Authors
    • Submit to JNM
    • Information for Authors
    • Assignment of Copyright
    • AQARA requirements
  • Info
    • Reviewers
    • Permissions
    • Advertisers
  • About
    • About Us
    • Editorial Board
    • Contact Information
  • More
    • Alerts
    • Feedback
    • Help
    • SNMMI Journals
  • SNMMI
    • JNM
    • JNMT
    • SNMMI Journals
    • SNMMI

User menu

  • Subscribe
  • My alerts
  • Log in
  • My Cart

Search

  • Advanced search
Journal of Nuclear Medicine
  • SNMMI
    • JNM
    • JNMT
    • SNMMI Journals
    • SNMMI
  • Subscribe
  • My alerts
  • Log in
  • My Cart
Journal of Nuclear Medicine

Advanced Search

  • Home
  • Content
    • Current
    • Ahead of print
    • Past Issues
    • JNM Supplement
    • SNMMI Annual Meeting Abstracts
    • Continuing Education
    • JNM Podcasts
  • Subscriptions
    • Subscribers
    • Institutional and Non-member
    • Rates
    • Journal Claims
    • Corporate & Special Sales
  • Authors
    • Submit to JNM
    • Information for Authors
    • Assignment of Copyright
    • AQARA requirements
  • Info
    • Reviewers
    • Permissions
    • Advertisers
  • About
    • About Us
    • Editorial Board
    • Contact Information
  • More
    • Alerts
    • Feedback
    • Help
    • SNMMI Journals
  • View or Listen to JNM Podcast
  • Visit JNM on Facebook
  • Join JNM on LinkedIn
  • Follow JNM on Twitter
  • Subscribe to our RSS feeds

About the Cover

March 1, 2012; Volume 53,Issue 3
  • A
  • B
  • C
  • D
  • E
  • F
  • G
  • H
  • I
  • J
  • K
  • L
  • M
  • N
  • O
  • P
  • Q
  • R
  • S
  • T
  • U
  • V
  • W
  • X
  • Y
  • Z

  1. D'asseler, Yves

    1. You have access
      99mTc-Labeled Tricarbonyl His-CNA35 as an Imaging Agent for the Detection of Tumor Vasculature
      Gilles Mees, Rudi Dierckx, Koen Mertens, Simon Vermeire, Magali Van Steenkiste, Chris Reutelingsperger, Yves D'Asseler, Kathelijne Peremans, Nancy Van Damme and Christophe Van de Wiele
      Journal of Nuclear Medicine March 1, 2012, 53 (3) 464-471; DOI: https://doi.org/10.2967/jnumed.111.095794
  2. Dehdashti, Farrokh

    1. You have access
      Assessment of Progesterone Receptors in Breast Carcinoma by PET with 21-18F-Fluoro-16α,17α-[(R)-(1′-α-furylmethylidene)Dioxy]-19-Norpregn-4-Ene-3,20-Dione
      Farrokh Dehdashti, Richard Laforest, Feng Gao, Rebecca L. Aft, Carmen S. Dence, Dong Zhou, Kooresh I. Shoghi, Barry A. Siegel, John A. Katzenellenbogen and Michael J. Welch
      Journal of Nuclear Medicine March 1, 2012, 53 (3) 363-370; DOI: https://doi.org/10.2967/jnumed.111.098319
  3. Del Vecchio, Silvana

    1. You have access
      3′-Deoxy-3′-18F-Fluorothymidine PET/CT to Guide Therapy with Epidermal Growth Factor Receptor Antagonists and Bcl-xL Inhibitors in Non–Small Cell Lung Cancer
      Antonella Zannetti, Francesca Iommelli, Antonio Speranza, Marco Salvatore and Silvana Del Vecchio
      Journal of Nuclear Medicine March 1, 2012, 53 (3) 443-450; DOI: https://doi.org/10.2967/jnumed.111.096503
  4. Dence, Carmen S.

    1. You have access
      Assessment of Progesterone Receptors in Breast Carcinoma by PET with 21-18F-Fluoro-16α,17α-[(R)-(1′-α-furylmethylidene)Dioxy]-19-Norpregn-4-Ene-3,20-Dione
      Farrokh Dehdashti, Richard Laforest, Feng Gao, Rebecca L. Aft, Carmen S. Dence, Dong Zhou, Kooresh I. Shoghi, Barry A. Siegel, John A. Katzenellenbogen and Michael J. Welch
      Journal of Nuclear Medicine March 1, 2012, 53 (3) 363-370; DOI: https://doi.org/10.2967/jnumed.111.098319
  5. Dierckx, Rudi

    1. You have access
      99mTc-Labeled Tricarbonyl His-CNA35 as an Imaging Agent for the Detection of Tumor Vasculature
      Gilles Mees, Rudi Dierckx, Koen Mertens, Simon Vermeire, Magali Van Steenkiste, Chris Reutelingsperger, Yves D'Asseler, Kathelijne Peremans, Nancy Van Damme and Christophe Van de Wiele
      Journal of Nuclear Medicine March 1, 2012, 53 (3) 464-471; DOI: https://doi.org/10.2967/jnumed.111.095794
  6. Dierckx, Rudi A.

    1. You have access
      18F-FEAnGA for PET of β-Glucuronidase Activity in Neuroinflammation
      Inês F. Antunes, Janine Doorduin, Hidde J. Haisma, Philip H. Elsinga, Aren van Waarde, Antoon T.M. Willemsen, Rudi A. Dierckx and Erik F.J. de Vries
      Journal of Nuclear Medicine March 1, 2012, 53 (3) 451-458; DOI: https://doi.org/10.2967/jnumed.111.096388
  7. Dierckx, Rudi A.J.O.

    1. You have access
      Evaluation of 4′-[Methyl-11C]Thiothymidine in a Rodent Tumor and Inflammation Model
      Jun Toyohara, Philip H. Elsinga, Kiichi Ishiwata, Jurgen W.A. Sijbesma, Rudi A.J.O. Dierckx and Aren van Waarde
      Journal of Nuclear Medicine March 1, 2012, 53 (3) 488-494; DOI: https://doi.org/10.2967/jnumed.111.098426
  8. Doorduin, Janine

    1. You have access
      18F-FEAnGA for PET of β-Glucuronidase Activity in Neuroinflammation
      Inês F. Antunes, Janine Doorduin, Hidde J. Haisma, Philip H. Elsinga, Aren van Waarde, Antoon T.M. Willemsen, Rudi A. Dierckx and Erik F.J. de Vries
      Journal of Nuclear Medicine March 1, 2012, 53 (3) 451-458; DOI: https://doi.org/10.2967/jnumed.111.096388
Back to top
PreviousNext

In this issue

Journal of Nuclear Medicine: 53 (3)
Journal of Nuclear Medicine
Vol. 53, Issue 3
March 1, 2012
  • Table of Contents
  • Table of Contents (PDF)
  • About the Cover
  • Index by author

Issue highlights

  • Impact of 3,4-Dihydroxy-6-18F-Fluoro-l-Phenylalanine PET/CT on Managing Patients with Brain Tumors: The Referring Physician's Perspective
  • Bringing Physiology into PET of the Liver
  • Experimental Radionuclide Therapy of HER2-Expressing Xenografts Using Two-Step Targeting Nuclisome Particles
Sign up for alerts
  • Most Cited
  • Most Read
Loading
  • MIRD Pamphlet No. 28, Part 1: MIRDcalc—A Software Tool for Medical Internal Radiation Dosimetry
  • Absorbed Dose–Response Relationship in Patients with Gastroenteropancreatic Neuroendocrine Tumors Treated with [177Lu]Lu-DOTATATE: One Step Closer to Personalized Medicine
  • Prediction of 177Lu-DOTATATE PRRT Outcome Using Multimodality Imaging in Patients with Gastroenteropancreatic Neuroendocrine Tumors: Results from a Prospective Phase II LUMEN Study
  • Renal and Multiorgan Safety of 177Lu-PSMA-617 in Patients with Metastatic Castration-Resistant Prostate Cancer in the VISION Dosimetry Substudy
  • High-Temporal-Resolution Lung Kinetic Modeling Using Total-Body Dynamic PET with Time-Delay and Dispersion Corrections
More...
SNMMI

© 2025 SNMMI

Powered by HighWire